Sushma B. Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sushma B. Singh has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Avinash Shankar Kumbhar
Department of Chemistry, Savitribai Phule Pune University, Pune, 411007, India
4 shared publications Anup Kate
Department of Chemistry, Savitribai Phule Pune University, Pune-411007, India
2 shared publicationsAyesha Khan
Department of Chemistry, Savitribai Phule Pune University, Pune-, 411007, India
2 shared publicationsChaitra S. Todankar
Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai400076, India
2 shared publicationsNilima A. Vyas
Department of Chemistry , Savitribai Phule Pune University , Pune - 411007 , India
2 shared publications- Pushpangadan Indira Pradeepkumar
Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India
2 shared publications
Latest Publications
- 31 October 2022
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 61 (22) , 2546-2559
Targeting Parallel Topology of G-Quadruplex Structures by Indole- Fused Quindoline Scaffolds
Preferential stabilization of G-quadruplex (G4) structures using small-molecule ligands has emerged as an effective approach to develop anticancer drugs. Herein, we report the synthesis of three indole-fused quindoline derivatives with varying lengths of side chains (InqEt1, InqEt2, and InqPr2) as selective ligands for promoter G4 structures. The ligands stabilize the parallel topology of c-MYC and c-KIT1 promoter G4 DNAs over telomeric and duplex DNAs, as evident from the circular dichroism melting and polymerase stop-assay experiments. The lead ligand, InqPr2, downregulates the gene expression of c-MYC and c-KIT in HeLa and HepG2 cells, respectively, leading to apoptotic cell death. Molecular modeling and dynamics studies support the 2:1 binding stoichiometry revealed from the Job plot analysis and show the ligand's structural features that enable the preferential binding to the parallel G4 structures over other topologies. Our studies show that indole-fused quindoline derivatives can be harnessed as new molecular scaffolds for selective targeting of parallel G4 topologies.
- 31 October 2022
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 61 (22) , 2546-2559
Targeting Parallel Topology of G-Quadruplex Structures by Indole- Fused Quindoline Scaffolds
Preferential stabilization of G-quadruplex (G4) structures using small-molecule ligands has emerged as an effective approach to develop anticancer drugs. Herein, we report the synthesis of three indole-fused quindoline derivatives with varying lengths of side chains (InqEt1, InqEt2, and InqPr2) as selective ligands for promoter G4 structures. The ligands stabilize the parallel topology of c-MYC and c-KIT1 promoter G4 DNAs over telomeric and duplex DNAs, as evident from the circular dichroism melting and polymerase stop-assay experiments. The lead ligand, InqPr2, downregulates the gene expression of c-MYC and c-KIT in HeLa and HepG2 cells, respectively, leading to apoptotic cell death. Molecular modeling and dynamics studies support the 2:1 binding stoichiometry revealed from the Job plot analysis and show the ligand's structural features that enable the preferential binding to the parallel G4 structures over other topologies. Our studies show that indole-fused quindoline derivatives can be harnessed as new molecular scaffolds for selective targeting of parallel G4 topologies.
- 9 February 2022
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 24 (10) , 6238-6255
Stabilization and fluorescence light-up of G-quadruplex nucleic acids using indolyl-quinolinium based probes
G-Quadruplexes (G4s) are four-stranded motifs formed by G-rich nucleic acid sequences. These structures harbor significant biological importance as they are involved in telomere maintenance, transcription, and translation. Owing to their dynamic and polymorphic nature, G4 structures relevant for therapeutic applications need to be stabilized by small-molecule ligands. Some of these ligands turn on fluorescence upon binding to G4 structures, which provides a powerful detection platform for G4 structures. Herein, we report the synthesis of fluorescent ligands based on the indolyl-quinolinium moiety to specifically stabilize G4 structures and sense DNA. CD titration and melting experiments have shown that the lead ligand induces the formation of parallel G4 with preferential stabilization of the c-MYC and c-KIT1 promoter G4s over the telomeric, h-RAS1 G4, and duplex DNA. Fluorimetric titration data revealed fluorescence enhancement when these ligands interact with G4 DNA structures. The fluorescence lifetime experiment of the ligand with different DNAs revealed three excited state lifetimes (ns), which indicates more than one binding site. MD studies showed that the ligand exhibits 3 : 1 stoichiometry of binding with c-MYC G4 DNA and revealed the unique structural features, which impart selectivity toward parallel topology. The ligand was found to have low cytotoxicity and exhibited preferential staining of DNA over RNA. Collectively, the results presented here offer avenues to harness indolyl-quinolinium scaffolds for sensing and selective stabilization of G4 structures.
- 9 February 2022
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 24 (10) , 6238-6255
Stabilization and fluorescence light-up of G-quadruplex nucleic acids using indolyl-quinolinium based probes
G-Quadruplexes (G4s) are four-stranded motifs formed by G-rich nucleic acid sequences. These structures harbor significant biological importance as they are involved in telomere maintenance, transcription, and translation. Owing to their dynamic and polymorphic nature, G4 structures relevant for therapeutic applications need to be stabilized by small-molecule ligands. Some of these ligands turn on fluorescence upon binding to G4 structures, which provides a powerful detection platform for G4 structures. Herein, we report the synthesis of fluorescent ligands based on the indolyl-quinolinium moiety to specifically stabilize G4 structures and sense DNA. CD titration and melting experiments have shown that the lead ligand induces the formation of parallel G4 with preferential stabilization of the c-MYC and c-KIT1 promoter G4s over the telomeric, h-RAS1 G4, and duplex DNA. Fluorimetric titration data revealed fluorescence enhancement when these ligands interact with G4 DNA structures. The fluorescence lifetime experiment of the ligand with different DNAs revealed three excited state lifetimes (ns), which indicates more than one binding site. MD studies showed that the ligand exhibits 3 : 1 stoichiometry of binding with c-MYC G4 DNA and revealed the unique structural features, which impart selectivity toward parallel topology. The ligand was found to have low cytotoxicity and exhibited preferential staining of DNA over RNA. Collectively, the results presented here offer avenues to harness indolyl-quinolinium scaffolds for sensing and selective stabilization of G4 structures.
- 12 June 2018
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 57 (13) , 7524-7535
Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)–Platinum(II) Polypyridyl Complexes
Two heteronuclear ruthenium(II)–platinum(II) complexes [Ru(bpy)2(BPIMBp)PtCl2]2+ (3) and [Ru(phen)2(BPIMBp)PtCl2]2+ (4), where bpy = 2,2′-bipyridine, phen = 1,10-phenanthroline, and BPIMBp = 1,4′-bis[(2-pyridin-2-yl)-1H-imidazol-1-ylmethyl]-1,1′-biphenyl, have been designed and synthesized from their mononuclear precursors [Ru(bpy)2(BPIMBp)]2+ (1) and [Ru(phen)2(BPIMBp)]2+ (2) as multitarget molecules for Alzheimer’s disease (AD). The inclusion of the cis-PtCl2 moiety facilitates the covalent interaction of Ru(II) polypyridyl complexes with amyloid β (Aβ) peptide. These multifunctional complexes act as inhibitors of acetylcholinesterase (AChE), Aβ aggregation, and Cu-induced oxidative stress and protect neuronal cells against Aβ-toxicity. The study highlights the design of metal based anti-Alzheimer’s disease (AD) systems.
- 12 June 2018
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 57 (13) , 7524-7535
Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)–Platinum(II) Polypyridyl Complexes
Two heteronuclear ruthenium(II)–platinum(II) complexes [Ru(bpy)2(BPIMBp)PtCl2]2+ (3) and [Ru(phen)2(BPIMBp)PtCl2]2+ (4), where bpy = 2,2′-bipyridine, phen = 1,10-phenanthroline, and BPIMBp = 1,4′-bis[(2-pyridin-2-yl)-1H-imidazol-1-ylmethyl]-1,1′-biphenyl, have been designed and synthesized from their mononuclear precursors [Ru(bpy)2(BPIMBp)]2+ (1) and [Ru(phen)2(BPIMBp)]2+ (2) as multitarget molecules for Alzheimer’s disease (AD). The inclusion of the cis-PtCl2 moiety facilitates the covalent interaction of Ru(II) polypyridyl complexes with amyloid β (Aβ) peptide. These multifunctional complexes act as inhibitors of acetylcholinesterase (AChE), Aβ aggregation, and Cu-induced oxidative stress and protect neuronal cells against Aβ-toxicity. The study highlights the design of metal based anti-Alzheimer’s disease (AD) systems.
- 13 September 2016
- Published by Wiley in Chemistry – A European Journal
- Vol. 22 (44) , 15760-15771
Honeycomb‐like Ordered Assembly of DNA Induced by Flexible Binuclear Ruthenium(II)–Polypyridyl Complexes
A series of binuclear ruthenium(II)–polypyridyl complexes of the type [Ru2(N‐N)4(BPIMBp)]4+, in which N‐N is 2,2′‐bipyridine (bpy; 1), 1,10‐phenanthroline (phen; 2), dipyrido[3,2‐d:2′,3‐f] quinoxaline (dpq; 3), dipyrido[3,2‐a:2′,3′‐c] phenanzine (dppz; 4), and 1,4′‐bis[(2‐pyridin‐2‐yl)‐1H‐imidazol‐1‐yl)methyl]‐1,1′‐biphenyl (BPIMBp) is a bridging ligand, have been synthesized and characterized. These complexes are charged (4+) cations and flexible due to the −CH2 group of the bridging ligand and possess terminal ligands with variable intercalative abilities. The interaction of complexes 1–4 with calf thymus DNA (CT‐DNA) was explored by using UV/Vis absorption spectroscopy, steady‐state emission, emission quenching with K4[Fe(CN)6], ethidium bromide displacement assay, Hoechst displacement assay, and viscosity measurements and revealed a groove‐binding mode for all the complexes through a spacer and an intercalative mode for complexes 3 and 4. A decrease in the viscosity of DNA revealed bending and coiling of DNA, an initial step toward aggregation. Interestingly, a distinctive honeycomb‐like ordered assembly of the DNA–complex species was visualized by fluorescence microscopy in the solution state. The use of SEM and AFM confirmed the disordered self‐organization of the DNA–complex adduct on evaporation of the solvent. The small orderly nanosized DNA aggregates were confirmed by means of circular dichroism, dynamic light scattering (DLS), and TEM. These complexes are moderately cytotoxic against three different cell lines, namely, MCF‐7, HeLa, and HL‐60.
- 13 September 2016
- Published by Wiley in Chemistry – A European Journal
- Vol. 22 (44) , 15760-15771
Honeycomb‐like Ordered Assembly of DNA Induced by Flexible Binuclear Ruthenium(II)–Polypyridyl Complexes
A series of binuclear ruthenium(II)–polypyridyl complexes of the type [Ru2(N‐N)4(BPIMBp)]4+, in which N‐N is 2,2′‐bipyridine (bpy; 1), 1,10‐phenanthroline (phen; 2), dipyrido[3,2‐d:2′,3‐f] quinoxaline (dpq; 3), dipyrido[3,2‐a:2′,3′‐c] phenanzine (dppz; 4), and 1,4′‐bis[(2‐pyridin‐2‐yl)‐1H‐imidazol‐1‐yl)methyl]‐1,1′‐biphenyl (BPIMBp) is a bridging ligand, have been synthesized and characterized. These complexes are charged (4+) cations and flexible due to the −CH2 group of the bridging ligand and possess terminal ligands with variable intercalative abilities. The interaction of complexes 1–4 with calf thymus DNA (CT‐DNA) was explored by using UV/Vis absorption spectroscopy, steady‐state emission, emission quenching with K4[Fe(CN)6], ethidium bromide displacement assay, Hoechst displacement assay, and viscosity measurements and revealed a groove‐binding mode for all the complexes through a spacer and an intercalative mode for complexes 3 and 4. A decrease in the viscosity of DNA revealed bending and coiling of DNA, an initial step toward aggregation. Interestingly, a distinctive honeycomb‐like ordered assembly of the DNA–complex species was visualized by fluorescence microscopy in the solution state. The use of SEM and AFM confirmed the disordered self‐organization of the DNA–complex adduct on evaporation of the solvent. The small orderly nanosized DNA aggregates were confirmed by means of circular dichroism, dynamic light scattering (DLS), and TEM. These complexes are moderately cytotoxic against three different cell lines, namely, MCF‐7, HeLa, and HL‐60.
- Open Access
- 24 May 2016
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (33) , 13114-13125
Antiproliferative activity of ruthenium(ii) arene complexes with mono- and bidentate pyridine-based ligands
The antitumour activity of RuII arene complexes with N-donor ligands is realised through inhibition of cell division accompanied by caspase-dependent apoptosis.
- 24 May 2016
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (33) , 13114-13125
Open AccessAntiproliferative activity of ruthenium(ii) arene complexes with mono- and bidentate pyridine-based ligands
The antitumour activity of RuII arene complexes with N-donor ligands is realised through inhibition of cell division accompanied by caspase-dependent apoptosis.
- 23 December 2015
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (7) , 3003-3012
Copper( ii ) mixed-ligand polypyridyl complexes with doxycycline – structures and biological evaluation
Structures and biological evaluation of Cu( ii ) mixed-ligand polypyridyl complexes with doxycycline of the type [Cu(doxycycline)(L)(H 2 O) 2 ](NO 3 ) 2 , L = 2,2′-bipyridine (bpy, 1 ), 1,10-phenanthroline (phen, 2 ), dipyrido[3,2- d :2′,3′- f ]quinoxaline (dpq, 3 ) and dipyrido[3,2- a :2′,3′- c ]phenazine (dppz, 4 ).
- 23 December 2015
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (7) , 3003-3012
Copper( ii ) mixed-ligand polypyridyl complexes with doxycycline – structures and biological evaluation
Structures and biological evaluation of Cu( ii ) mixed-ligand polypyridyl complexes with doxycycline of the type [Cu(doxycycline)(L)(H 2 O) 2 ](NO 3 ) 2 , L = 2,2′-bipyridine (bpy, 1 ), 1,10-phenanthroline (phen, 2 ), dipyrido[3,2- d :2′,3′- f ]quinoxaline (dpq, 3 ) and dipyrido[3,2- a :2′,3′- c ]phenazine (dppz, 4 ).